UPDATE: Goldman Sachs Downgrades Cepheid to Neutral on Lack of Catalysts


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Goldman Sachs reduced its rating on Cepheid (NASDAQ: CPHD) from Buy to Neutral and reduced its price target from $42 to $32. Goldman Sachs commented, "We downgrade shares of CPHD to Neutral from Buy and lower our 6-month price target to $32 ($42 previously) as we believe CPHD is now a “show-me” story that requires several quarters of solid management execution (following several missteps) to garner the premium valuation is had previously ascertained. Since adding CPHD to the Buy List on 9/23/11, the shares are -19.3% vs. the S&P 500 +19.7%, given operational missteps and slowing growth. Over the past 12 months, CPHD is -8.2% vs. S&P 500 +9.9%."Cepheid closed at $30.53 on Friday.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorDowngradesIntraday UpdateAnalyst RatingsGoldman Sachs